Sepragen Corporation
   "Innovators in Separations Technology"

CONTACT   SITE MAP   INFORMATION   LINKS

 

 
Home
About
Products
Processes
Contact

The Team
News

Support
Investors




Subscribe
Unsubscribe


...

 


About Sepragen


Enabling Biological Drugs Scale Up & Production


 

 

 

See what our customers think

Sepragen’s products or tools are used to manufacture over 12 FDA approved drugs including Kogenate®, Alphanate®, Neupogen®, and GammaGrand®* along with a multitude of other drugs currently in clinical trials.

Sepragen’s customers range from manufacturers of recombinant biological protein and peptides, vaccines manufacturers, derivates, genetic therapy vectors, monoclonal antibody producers for diagnostic and therapeutic use and enzyme producers. Our international list of customers on four continents includes a combination of big pharma and more entrepreneurial biotech companies: Amgen, Bayer, Alpha Therapeutics, Chiron, Cohesion, Burroughs Wellcome, Eli Lilly, Baxter, Asahi Glass, Aventis, Merck, Human Genome Sciences, CSL, Smithkline Beecham, Chugai, Schering Plough, IDEC, Hoffman La Roche, Roche Molecular Systems, Genencor, Berlex, Dade, Yoshitomi.

In one instance, over 40,000 liters of human plasma is being treated every 6 hours on 2,800 liters of Sepragen columns to produce tens of kilograms of an injectable protein drug. 

*Kogenate is a registered trademark of Bayer, Alphanate® is a registered trademark of Alpha Therapeutics, Neupogen® is a registered trademark of Amgen, and GammaGrand® is a registered trademark of Baxter.


 Home|About
 
If you have any questions or comments,
please fill out the information request/feedback form.
Copyright © 1998- 2003 Sepragen Corporation